4.6 Article

CK2 inhibition induced PDK4-AMPK axis regulates metabolic adaptation and survival responses in glioma

期刊

EXPERIMENTAL CELL RESEARCH
卷 344, 期 1, 页码 132-142

出版社

ELSEVIER INC
DOI: 10.1016/j.yexcr.2016.03.017

关键词

CK2; PDK4; AMPK; CREB; Glioblastoma

资金

  1. Department of Biotechnology DBT [BT/MED/30/SP11016/2015]
  2. Council of Scientific and Industrial Research (CSIR, Government of India)
  3. DBT

向作者/读者索取更多资源

Understanding mechanisms that link aberrant metabolic adaptation and pro-survival responses in glioma cells is crucial towards the development of new anti-glioma therapies. As we have previously reported that CK2 is associated with glioma cell survival, we evaluated its involvement in the regulation of glucose metabolism. Inhibition of CK2 increased the expression of metabolic regulators, PDK4 and AMPK along with the key cellular energy sensor CREB. This increase was concomitant with altered metabolic profile as characterized by decreased glucose uptake in a PDK4 and AMPK dependent manner. Increased PDK4 expression was CREB dependent, as exogenous inhibition of CREB functions abrogated CK2 inhibitor mediated increase in PDK4 expression. Interestingly, PDK4 regulated AMPK phosphorylation which in turn affected cell viability in CK2 inhibitor treated glioma cells. CK2 inhibitor 4,5,6,7-Tetrabromobenzotriazole (TBB) significantly retarded the growth of glioma xenografts in athymic nude mouse model. Coherent with the in vitro findings, elevated senescence, pAMPK and PDK4 levels were also observed in TBB-treated xenograft tissue. Taken together, CK2 inhibition in glioma cells drives the PDK4-AMPK axis to affect metabolic profile that has a strong bearing on their survival. (C) 2016 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell Biology

Three-dimensional bioprinted glioblastoma microenvironments model cellular dependencies and immune interactions

Min Tang, Qi Xie, Ryan C. Gimple, Zheng Zhong, Trevor Tam, Jing Tian, Reilly L. Kidwell, Qiulian Wu, Briana C. Prager, Zhixin Qiu, Aaron Yu, Zhe Zhu, Pinar Mesci, Hui Jing, Jacob Schimelman, Pengrui Wang, Derrick Lee, Michael H. Lorenzini, Deobrat Dixit, Linjie Zhao, Shruti Bhargava, Tyler E. Miller, Xueyi Wan, Jing Tang, Bingjie Sun, Benjamin F. Cravatt, Alysson R. Muotri, Shaochen Chen, Jeremy N. Rich

CELL RESEARCH (2020)

Article Oncology

The RNA m6A Reader YTHDF2 Maintains Oncogene Expression and Is a Targetable Dependency in Glioblastoma Stem Cells

Deobrat Dixit, Briana C. Prager, Ryan C. Gimple, Hui Xian Poh, Yang Wang, Qiulian Wu, Zhixin Qiu, Reilly L. Kidwell, Leo J. Y. Kim, Qi Xie, Kristoffer Vitting-Seerup, Shruti Bhargava, Zhen Dong, Li Jiang, Zhe Zhu, Petra Hamerlik, Samie R. Jaffrey, Jing Crystal Zhao, Xiuxing Wang, Jeremy N. Rich

Summary: Research reveals that m6A mRNA modifications are upregulated in glioblastoma stem cells, with the key m6A reader YTHDF2 stabilizing important transcripts such as MYC. Targeting the YTHDF2-MYC-IGFBP3 axis could potentially be a novel therapeutic approach for glioblastoma. Epitranscriptomics have the potential to reveal specific vulnerabilities in cancer cells that can be targeted for treatment.

CANCER DISCOVERY (2021)

Review Oncology

Metabolic reprogramming in prostate cancer

Fahim Ahmad, Murali Krishna Cherukuri, Peter L. Choyke

Summary: While low-risk localized prostate cancer has a good prognosis with effective treatments, metastatic prostate cancer remains incurable and treatment resistance is a major issue. Resistance is primarily driven by tumor heterogeneity, altered genetic signatures, and metabolic reprogramming enabling tumors to adapt to drugs. Understanding prostate cancer metabolism may offer insights into therapy-induced adaptive responses and more durable therapeutic outcomes.

BRITISH JOURNAL OF CANCER (2021)

Article Cell Biology

Repurposing Methotrexate in Dampening SARS-CoV2-S1-Mediated IL6 Expression: Lessons Learnt from Lung Cancer

Pruthvi Gowda, Shruti Patrick, Shanker Datt Joshi, Rajesh Kumar Kumawat, Ellora Sen

Summary: SARS-CoV-2 infection is associated with uncontrolled inflammation and loss of ACE2 function, similar to characteristics seen in lung cancer. Analysis showed an inverse correlation between ACE2 and IL6 in lung adenocarcinoma, and treatment with MTx dampened the inflammatory response while restoring ACE2 expression in CoV-2-SRBD transfected cells. Repurposing MTx as a therapy against inflammation regulators in SARS-CoV-2 infection is worthy of investigation.

INFLAMMATION (2022)

Article Cell Biology

YAP1-mediated regulation of mitochondrial dynamics in IDH1 mutant gliomas

Shruti Patrick, Pruthvi Gowda, Kirti Lathoria, Vaishali Suri, Ellora Sen

Summary: The mutation of the IDH1 gene results in decreased nuclear levels of YAP1 and TFAM, leading to mitochondrial fragmentation and ROS generation, as well as altered localization of TERT in mitochondria, which ultimately affects cell apoptosis. Treatment with the Src kinase inhibitor bosutinib further enhances ROS production and induces apoptosis, indicating a crucial role of YAP1 in regulating redox homeostasis through mitochondrial dysfunction and TERT shuttling.

JOURNAL OF CELL SCIENCE (2021)

Article Biochemistry & Molecular Biology

Brg1 mutation alters oxidative stress responses in glioblastoma

Pruthvi Gowda, Kirti Lathoria, Sonia B. Umdor, Ellora Sen

Summary: The ATPase domain of BRG1 plays a crucial role in regulating redox homeostasis and sensitivity to oxidative stressors in glioma cells. BRG1 mutation creates vulnerability to elevated ROS levels, which can be therapeutically exploited, with ROS stressors as a promising therapeutic target for the treatment of BRG1-mutant cancers.

NEUROCHEMISTRY INTERNATIONAL (2021)

Article Cell Biology

Glioblastoma stem cells reprogram chromatin in vivo to generate selective therapeutic dependencies on DPY30 and phosphodiesterases

Deobrat Dixit, Briana C. Prager, Ryan C. Gimple, Tyler E. Miller, Qiulian Wu, Shira Yomtoubian, Reilly L. Kidwell, Deguan Lv, Linjie Zhao, Zhixin Qiu, Guoxin Zhang, Derrick Lee, Donglim Esther Park, Robert J. Wechsler-Reya, Xiuxing Wang, Shideng Bao, Jeremy N. Rich

Summary: In this study, DPY30 was identified as an in vivo-specific glioblastoma dependency using in vivo genetic screening. By examining the chromatin characteristics of glioblastoma stem cells, DPY30 was found to regulate angiogenesis and hypoxia pathways critical for tumor growth. However, DPY30 was dispensable in vitro. Additionally, DPY30 was shown to regulate the downstream effector PDE4B, with the inhibitor rolipram preferentially targeting DPY30-expressing cells and impairing the growth of patient-derived xenograft tumors in mice.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Oncology

Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells

Zhixin Qiu, Linjie Zhao, Jia Z. Shen, Zhengyu Liang, Qiulian Wu, Kailin Yang, Lihua Min, Ryan C. Gimple, Qiyuan Yang, Shruti Bhargava, Chunyu Jin, Cheryl Kim, Denise Hinz, Deobrat Dixit, Jean A. Bernatchez, Briana C. Prager, Guoxin Zhang, Zhen Dong, Deguan Lv, Xujun Wang, Leo J. Y. Kim, Zhe Zhu, Katherine A. Jones, Ye Zheng, Xiuxing Wang, Jair L. Siqueira-Neto, Lukas Chavez, Xiang-Dong Fu, Charles Spruck, Jeremy N. Rich

Summary: This study identifies the YY1-CDK9 transcription elongation complex as a crucial factor in maintaining glioblastoma stemness and therapeutic resistance. Targeting this complex can activate interferon response, reduce regulatory T-cell infiltration, and enhance the efficacy of immune checkpoint therapy.

CANCER DISCOVERY (2022)

Article Oncology

β2-Microglobulin Maintains Glioblastoma Stem Cells and Induces M2-like Polarization of Tumor-Associated Macrophages

Daqi Li, Qian Zhang, Lu Li, Kexin Chen, Junlei Yang, Deobrat Dixit, Ryan C. Gimple, Shusheng Ci, Chenfei Lu, Lang Hu, Jiancheng Gao, Danyang Shan, Yangqing Li, Junxia Zhang, Zhumei Shi, Danling Gu, Wei Yuan, Qiulian Wu, Kailin Yang, Linjie Zhao, Zhixin Qiu, Deguang Lv, Wei Gao, Hui Yang, Fan Lin, Qianghu Wang, Jianghong Man, Chaojun Li, Weiwei Tao, Sameer Agnihotri, Xu Qian, Yu Shi, Yongping You, Nu Zhang, Jeremy N. Rich, Xiuxing Wang

Summary: The study reveals the tumor-promoting functions of B2M in glioblastoma and suggests potential therapeutic strategies for targeting tumor cells and the immunosuppressive microenvironment. B2M activation leads to the maintenance of stem-like neoplastic populations and induces an anti-inflammatory state, while promoting the polarization of macrophages towards an M2-like phenotype. Inhibition of B2M could attenuate glioblastoma stem cell survival, self-renewal, and tumor growth.

CANCER RESEARCH (2022)

Article Cell Biology

PDGF signaling inhibits mitophagy in glioblastoma stem cells through N6-methyladenosine

Deguan Lv, Ryan C. Gimple, Cuiqing Zhong, Qiulian Wu, Kailin Yang, Briana C. Prager, Bhaskar Godugu, Zhixin Qiu, Linjie Zhao, Guoxin Zhang, Deobrat Dixit, Derrick Lee, Jia Z. Shen, Xiqing Li, Qi Xie, Xiuxing Wang, Sameer Agnihotri, Jeremy N. Rich

Summary: Dysregulated growth factor receptor pathways, RNA modifications, and metabolism each promote tumor heterogeneity. PDGF signaling induces m(6)A accumulation in GBM stem cells to regulate mitophagy. PDGF-METTL3-OPTN signaling is identified as a therapeutic target for GBM treatment.

DEVELOPMENTAL CELL (2022)

Article Cell Biology

PRMT1 driven PTX3 regulates ferritinophagy in glioma

Kirti Lathoria, Pruthvi Gowda, Sonia B. Umdor, Shruti Patrick, Vaishali Suri, Ellora Sen

Summary: Mutations in the Krebs cycle enzyme IDH1 are associated with better prognosis in gliomas. The study reveals that IDH1 mutant gliomas have diminished expression of the PRMT1-PTX3 axis, leading to dysregulation of autophagy and ferritinophagy. The findings suggest that targeting the PRMT1-PTX3 ferritinophagy regulatory circuit could be a potential therapeutic strategy.

AUTOPHAGY (2023)

Article Biochemistry & Molecular Biology

DHODH inhibition impedes glioma stem cell proliferation, induces DNA damage, and prolongs survival in orthotopic glioblastoma xenografts

Raffaella Spina, Ian Mills, Fahim Ahmad, Chixiang Chen, Heather M. Ames, Jeffrey A. Winkles, Graeme F. Woodworth, Eli E. Bar

Summary: Glioma stem cells (GSCs) are sensitive to perturbations in de novo pyrimidine synthesis, and EGFR amplification confers resistance. BAY2402234, an inhibitor of DHODH, effectively inhibits GSC proliferation and induces apoptosis and DNA damage. Clinical testing of BAY2402234 in primary glioblastoma patients lacking EGFR amplification is warranted.

ONCOGENE (2022)

Article Neurosciences

Pyruvate dehydrogenase kinase 1 promotes neuronal apoptosis upon Japanese encephalitis virus infection

Surajit Chakraborty, Ellora Sen, Anirban Basu

Summary: Infection by Japanese Encephalitis Virus (JEV) can lead to neuronal apoptosis. This study found that JEV infection can regulate the abundance of neuronal pyruvate dehydrogenase kinase 1 (PDK1), and inhibiting the upregulation of PDK1 can improve neuronal apoptosis and reduce the generation of reactive oxygen species.

IBRO NEUROSCIENCE REPORTS (2022)

Article Medicine, Research & Experimental

Sorting nexin 10 sustains PDGF receptor signaling in glioblastoma stem cells via endosomal protein sorting

Ryan C. Gimple, Guoxin Zhang, Shuai Wang, Tengfei Huang, Jina Lee, Suchet Taori, Deguan Lv, Deobrat Dixit, Matthew E. Halbert, Andrew R. Morton, Reilly L. Kidwell, Zhen Dong, Briana C. Prager, Leo J. Y. Kim, Zhixin Qiu, Linjie Zhao, Qi Xie, Qiulian Wu, Sameer Agnihotri, Jeremy N. Rich

Summary: In this study, the researchers found that SNX10 was selectively expressed in glioblastoma stem cells (GSCs) compared with non-neoplastic neural stem cells (NSCs). SNX10 was essential for GSC survival and promoted GSC proliferation and stem cell signaling pathways through posttranscriptional regulation of PDGFR tyrosine kinase. Targeting SNX10 expression decreased GSC viability and self-renewal capacity. High expression of SNX10 correlated with poor prognosis in glioblastoma patients.

JCI INSIGHT (2023)

Article Oncology

Dual Role of CXCL8 in Maintaining the Mesenchymal State of Glioblastoma Stem Cells and M2-Like Tumor-Associated Macrophages

Wei Yuan, Qian Zhang, Danling Gu, Chenfei Lu, Deobrat Dixit, Ryan C. Gimple, Yisu Gao, Jiancheng Gao, Daqi Li, Danyang Shan, Lang Hu, Lu Li, Yangqing Li, Shusheng Ci, Hao You, Linping Yan, Kexin Chen, Ningwei Zhao, Chuanhai Xu, Jianyun Lan, Dong Liu, Junxia Zhang, Zhumei Shi, Qiulian Wu, Kailin Yang, Linjie Zhao, Zhixin Qiu, Deguang Lv, Wei Gao, Hui Yang, Fan Lin, Qianghu Wang, Jianghong Man, Chaojun Li, Weiwei Tao, Sameer Agnihotri, Xu Qian, Stephen C. Mack, Nu Zhang, Yongping You, Jeremy N. Rich, Guan Sun, Xiuxing Wang

Summary: The study reveals the crucial roles of CXCL8 in maintaining the mesenchymal state of GSCs and M2-like TAM polarization in GBM, suggesting that targeting CXCL8 and its downstream effectors could effectively improve GBM treatment.

CLINICAL CANCER RESEARCH (2023)

暂无数据